Opexa's Tovaxin® for the Treatment of Multiple Sclerosis Granted Fast Track Designation by FDA
Opexa Therapeutics, 8 Nov 2011
Accessed on 27 Sep 2013 from http://www.opexatherapeutics.com/news-and-resources/press-releases/press-releases-details/2011/Opexas-Tovaxin-for-the-Treatment-of-Multiple-Sclerosis-Granted-Fast-Track-Designation-by-FDA/default.aspx.